Medifast, Inc. (MED)
12.00
+0.05
(+0.42%)
USD |
NYSE |
Aug 24, 16:00
12.02
+0.02
(+0.12%)
Pre-Market: 20:00
Medifast Enterprise Value : -8.031M for Aug. 24, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| August 24, 2026 | -8.031M |
| August 21, 2026 | -8.590M |
| August 20, 2026 | -12.28M |
| August 19, 2026 | -12.73M |
| August 18, 2026 | -15.97M |
| August 17, 2026 | -14.29M |
| August 14, 2026 | -14.29M |
| August 13, 2026 | -13.85M |
| August 12, 2026 | -12.62M |
| August 11, 2026 | -11.94M |
| August 10, 2026 | -7.025M |
| August 07, 2026 | -1.099M |
| August 06, 2026 | -6.689M |
| August 05, 2026 | -4.900M |
| August 04, 2026 | 4.044M |
| August 03, 2026 | -33.30M |
| July 31, 2026 | -32.29M |
| July 30, 2026 | -31.40M |
| July 29, 2026 | -34.42M |
| July 28, 2026 | -33.19M |
| July 27, 2026 | -31.40M |
| July 24, 2026 | -33.97M |
| July 23, 2026 | -36.54M |
| July 22, 2026 | -33.08M |
| July 21, 2026 | -24.58M |
| Date | Value |
|---|---|
| July 20, 2026 | -26.14M |
| July 17, 2026 | -27.49M |
| July 16, 2026 | -24.80M |
| July 15, 2026 | -23.35M |
| July 14, 2026 | -23.57M |
| July 13, 2026 | -18.88M |
| July 10, 2026 | -22.34M |
| July 09, 2026 | -22.79M |
| July 08, 2026 | -22.90M |
| July 07, 2026 | -20.44M |
| July 06, 2026 | -18.76M |
| July 02, 2026 | -19.66M |
| July 01, 2026 | -18.88M |
| June 30, 2026 | -23.57M |
| June 29, 2026 | -33.87M |
| June 26, 2026 | -35.98M |
| June 25, 2026 | -39.43M |
| June 24, 2026 | -37.65M |
| June 23, 2026 | -34.76M |
| June 22, 2026 | -30.31M |
| June 18, 2026 | -30.09M |
| June 17, 2026 | -27.76M |
| June 16, 2026 | -27.53M |
| June 15, 2026 | -20.08M |
| June 12, 2026 | -20.64M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| United Natural Foods, Inc. | 6.057B |
| Integrated BioPharma, Inc. | 2.707M |
| BioForce Nanosciences Holdings, Inc. | 130.84M |
| Skinvisible, Inc. | 6.832M |
| Nevis Brands, Inc. | 0.8626M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -3.10M |
| Revenue (Quarterly) | 76.38M |
| Total Expenses (Quarterly) | 79.48M |
| EPS Diluted (Quarterly) | -0.2784 |
| Gross Profit Margin (Quarterly) | 69.90% |
| Profit Margin (Quarterly) | -4.06% |
| Earnings Yield | -19.38% |
| Normalized Earnings Yield | -17.68 |